As efforts to find an effective vaccine for SARS-CoV-2 ramp up, an immunologist warns that fast-tracking of clinical trials could be catastrophic.
Scientists around the globe are working to develop an effective vaccine for the novel coronavirus, SARS-CoV-2. Until such a time, the world is reliant on physical distancing measures and personal protective equipment (PPE).
Some countries are using ‘track and trace’ systems to monitor the movements of people and notify those who have been in contact with somebody diagnosed with COVID-19.
Of course, a treatment for COVID-19 is also highly desirable. Gilead’s anti-viral drug remdesivir appears to accelerate recovery time in some people.